Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Five trials focused on how well tirzepatide controlled blood sugar. Four trials focused on its safety. Participants were given tirzepatide, a placebo, or other diabetes medications
Final Verdict: Research Comparison Feature Tirzepatide Retatrutide Receptor Targets GLP-1, GIP GLP-1, GIP, Glucagon Half-Life ~5 Days ~6 Days Max Published Weight Loss ~21% (72w) ~24% (48w) Liver Fat Reduction Moderate/High Extreme Primary Research Focus Glycemic Control Metabolic Reset / REE Future Outlook: Post-2025 Research Landscape As we look toward 2026 and beyond, the data from the Phase 3 TRIUMPH trials will likely solidify retatrutides position in the metabolic research hierarchy
Follow your treatment plan and call 111 or 999 if you are concerned about your symptoms
Can GHK-CU cause copper toxicity
US$ 24.16
US$ 24.03
US$ 28.32
US$ 26.07
US$ 20.68
US$ 24.02
